Rat back fascia contains CGRP and substance P-expressing pain nerve fibers that significantly increase in density during inflammation, potentially explaining non-specific low back pain.
Significant CGRP/SP fiber increasePain-sensing neuropeptide fibers multiplied in inflamed fascia layers, providing a biological basis for fascia as a low back pain source
What the researchers found
Nociceptive fibers positive for CGRP, substance P, and TRPV1 were found in all three layers of the rat thoracolumbar fascia (TLF). When inflammation was induced with complete Freund's adjuvant, CGRP- and SP-positive fiber density significantly increased in the inner layer (covering the multifidus muscle) and outer layer, but not the thick middle layer. Electrical stimulation of dorsal roots caused plasma extravasation in the TLF — direct functional evidence that fascia nociceptors can drive neurogenic inflammation.
Why it matters
Non-specific low back pain is one of the most common and costly health conditions worldwide, yet its source is often unclear. This study provides concrete evidence that fascia contains pain-sensing nerve fibers expressing key neuropeptides, and that these fibers proliferate during inflammation. This points to fascia as an underrecognized pain generator and potential therapeutic target.
How the study worked
Histological study in Sprague-Dawley rats. Immunohistochemistry using antibodies against CGRP, substance P, and TRPV1 identified nociceptive fibers across the three layers of the thoracolumbar fascia. Chronic inflammation was induced by injecting complete Freund's adjuvant. Neurogenic inflammation was tested by electrically stimulating dorsal roots and observing plasma extravasation in the fascia.
What this study cannot tell us
This is a rat study, and the fascia anatomy and innervation may differ from humans. Specific sample sizes and statistical values were not detailed in the abstract. The inflammation model (complete Freund's adjuvant) creates a severe inflammatory state that may not perfectly mimic clinical conditions like non-specific low back pain. The study demonstrates nociceptor presence but doesn't directly prove they cause pain perception.
How to read the evidence
This is a well-designed preclinical histological study in rats with complementary functional evidence (neurogenic inflammation). While it provides strong mechanistic evidence for fascia nociception, human validation is needed.
When this study was published
Published in 2016, this study was among the early investigations specifically characterizing nociceptive innervation of fascia. The findings have likely influenced subsequent research in fascial pain and manual therapy.
The bigger picture
Back pain research has traditionally focused on discs, joints, and muscles. This study adds fascia to the picture, showing it has its own pain-sensing nerve supply that responds to inflammation. Combined with growing clinical interest in fascia-based therapies (myofascial release, dry needling), this neuropeptide-level evidence helps validate fascia as a legitimate pain source and therapeutic target.
Questions still open
- Do human thoracolumbar fascia show the same CGRP and substance P fiber density changes during chronic back pain?
- Could therapies targeting fascia neuropeptides (like CGRP blockers) help treat non-specific low back pain?
- Why does the middle layer of the fascia not show increased nociceptor density during inflammation?
Common questions
Can fascia cause back pain?
What are CGRP and substance P, and what do they do in fascia?
Read the original research
Evidence for the existence of nociceptors in rat thoracolumbar fascia.
Journal of bodywork and movement therapies, 20(3), 623-8
Citation
Mense, Siegfried; Hoheisel, Ulrich. (2016). Evidence for the existence of nociceptors in rat thoracolumbar fascia.. Journal of bodywork and movement therapies, 20(3), 623-8. https://doi.org/10.1016/j.jbmt.2016.01.006